Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

Back to Top

Mark Rapoport, MD, FRCPC

Deputy Editor for Research and Practice

Mark Rapoport, MD, FRCPC
Associate Professor of Psychiatry, University of Toronto
Staff Geriatric Psychiatrist, Sunnybrook Health Sciences Centre
Past-President, Canadian Academy of Geriatric Psychiatry

Dr. Mark Rapoport is an associate professor in the geriatric psychiatry division of the department of psychiatry at the University of Toronto, a clinical scientist at Sunnybrook Health Sciences Centre, and President of the Canadian Academy of Geriatric Psychiatry (CAGP, 2012-2016).  He is also a member of the Canadian Driving Research Initiative for Vehicular Safety in the Elderly (CanDRIVE), and an associate editor of the Canadian Geriatrics Journal.  Dr. Rapoport received his medical degree from McMaster University in 1995, and subsequently trained in psychiatry at the University of Toronto.  He founded the CAGP National Review Course in Geriatric Psychiatry in 2012, an annual event that won two awards from the Canadian Psychiatric Association (CPA): The 2014 Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada (academic), and the 2016 Paul Patterson Award for Innovations in Education Leadership. He was the scientific co-chair for the 2009 International Psychogeriatric Association Congress in Montreal, Quebec.  He is a Fellow of the CPA, and won the 2014 CAGP Award for Outstanding Contributions in Geriatric Psychiatry.  His main areas of research are traumatic brain injury in the elderly and the risk of motor vehicle collisions associated with neurological and psychiatric diseases and their treatments, and he has received research funding from the Canadian Institute of Health Research, the Canadian Consortium on Neurodegeneration and Aging, and other peer-reviewed funding agencies.

After serving as an Assistant Editor, Dr. Rapoport became the Deputy Editor for the Research and Practice section of the IPA Bulletin in 2016. He regularly writes on recent advances in the field.


Acadia Pharmaceuticals Otsuka Pharmaceuticals Cambridge University Press Avanir Pharmaceuticals


555 E. Wells St.
Suite 1100
Milwaukee, WI 53202
United States

Tel: +1.414.918.9889
Fax: +1.414.276.3349

IPA Briefs

Sign up for IPA Briefs and receive the latest announcements from IPA.

© International Psychogeriatric Association. All rights reserved.